Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

FOX(M1) News--It Is Cancer

(2013) M. Halasi et al.   MOLECULAR CANCER THERAPEUTICS

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53

(2011) E K A Millar et al.   BRITISH JOURNAL OF CANCER

FoxM1: A Master Regulator of Tumor Metastasis

(2011) P. Raychaudhuri et al.   CANCER RESEARCH

New Developments in Hormone Receptor-Positive Disease

(2010) M. J. Piccart-Gebhart   ONCOLOGIST

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age

(2009) S. Mook et al.   ANNALS OF ONCOLOGY

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

(2009) Marieke E. Straver et al.   BREAST CANCER RESEARCH AND TREATMENT

A Conserved Phosphorylation Site within the Forkhead Domain of FoxM1B Is Required for Its Activation by Cyclin-CDK1

(2009) Yi-Ju Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer

(2008) Nuran Bektas et al.   BMC CANCER

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

(2008) Stella Mook et al.   BREAST CANCER RESEARCH AND TREATMENT